文献速递临床试验与 GCP真实世界研究与卫生经济

机器人辅助与传统腹腔镜手术治疗直肠癌患者中转开腹风险比较:ROLARR随机临床试验

Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial.
PubMed 文献 · JAMA · 2017-01-01

ROLARR随机临床试验在10个国家29个中心纳入471例适合根治性切除的直肠腺癌患者,比较机器人辅助与传统腹腔镜直肠癌切除的中转开腹风险。机器人辅助组中转开腹率为8.1%(19/236),传统腹腔镜组为12.2%(28/230),差异未达统计学显著(调整OR=0.61,95%CI 0.31-1.21,P=0.16)。环周切缘阳性率及其他8个预设次要终点两组均无显著差异。

要点

  • 机器人辅助组中转开腹率8.1%(19/236),传统腹腔镜组12.2%(28/230),差异无统计学意义(P=0.16)。
  • 环周切缘阳性率机器人辅助组5.1%(12/235),传统腹腔镜组6.3%(14/224),差异无统计学意义(P=0.56)。
  • 其他8个预设次要终点包括术中并发症、术后并发症、30天死亡率等均无显著差异。

核心结论

  • 在适合根治性切除的直肠腺癌患者中,机器人辅助腹腔镜手术与传统腹腔镜手术相比未显著降低中转开腹风险。
  • 这些发现提示,由机器人手术经验各异的术者实施时,机器人辅助腹腔镜手术在直肠癌切除中未带来优势。

研究设计与样本

  • 随机临床试验,比较机器人辅助与传统腹腔镜手术治疗直肠腺癌。
  • 在10个国家29个中心由40名术者实施,纳入471例适合根治性切除的直肠腺癌患者。
  • 患者随机分为机器人辅助组(n=237)和传统腹腔镜组(n=234)。
  • 招募时间为2011年1月7日至2014年9月30日,随访在30天和6个月时进行,最终随访日期为2015年6月16日。
  • 手术方式为高位(上段直肠)或低位(全直肠)前切除术或腹会阴切除术(直肠和会阴)。

主要发现

  • 总体中转开腹率为10.1%:机器人辅助组19/236(8.1%),传统腹腔镜组28/230(12.2%);未调整风险差=4.1%(95%CI -1.4%至9.6%),调整OR=0.61(95%CI 0.31至1.21),P=0.16。
  • 总体环周切缘阳性率为5.7%:传统腹腔镜组14/224(6.3%),机器人辅助组12/235(5.1%);未调整风险差=1.1%(95%CI -3.1%至5.4%),调整OR=0.78(95%CI 0.35至1.76),P=0.56。
  • 其他8个预设次要终点包括术中并发症、术后并发症、手术层面、30天死亡率、膀胱功能障碍和性功能障碍,两组间均未显示统计学显著差异。
  • 共471例随机患者(平均[SD]年龄64.9[11.0]岁;男性320例[67.9%]),466例(98.9%)完成研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Robotic rectal cancer surgery is gaining popularity, but limited data are available regarding safety and efficacy. OBJECTIVE: To compare robotic-assisted vs conventional laparoscopic surgery for risk of conversion to open laparotomy among patients undergoing resection for rectal cancer. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial comparing robotic-assisted vs conventional laparoscopic surgery among 471 patients with rectal adenocarcinoma suitable for curative resection conducted at 29 sites across 10 countries, including 40 surgeons. Recruitment of patients was from January 7, 2011, to September 30, 2014, follow-up was conducted at 30 days and 6 months, and final follow-up was on June 16, 2015. INTERVENTIONS: Patients were randomized to robotic-assisted (n = 237) or conventional (n = 234) laparoscopic rectal cancer resection, performed by either high (upper rectum) or low (total rectum) anterior resection or abdominoperineal resection (rectum and perineum). MAIN OUTCOMES AND MEASURES: The primary outcome was conversion to open laparotomy. Secondary end points included intraoperative and postoperative complications, circumferential resection margin positivity (CRM+) and other pathological outcomes, quality of life (36-Item Short Form Survey and 20-item Multidimensional Fatigue Inventory), bladder and sexual dysfunction (International Prostate Symptom Score, International Index of Erectile Function, and Female Sexual Function Index), and oncological outcomes. RESULTS: Among 471 randomized patients (mean [SD] age, 64.9 [11.0] years; 320 [67.9%] men), 466 (98.9%) completed the study. The overall rate of conversion to open laparotomy was 10.1%: 19 of 236 patients (8.1%) in the robotic-assisted laparoscopic group and 28 of 230 patients (12.2%) in the conventional laparoscopic group (unadjusted risk difference = 4.1% [95% CI, -1.4% to 9.6%]; adjusted odds ratio = 0.61 [95% CI, 0.31 to 1.21]; P = .16). The overall CRM+ rate was 5.7%; CRM+ occurred in 14 (6.3%) of 224 patients in the conventional laparoscopic group and 12 (5.1%) of 235 patients in the robotic-assisted laparoscopic group (unadjusted risk difference = 1.1% [95% CI, -3.1% to 5.4%]; adjusted odds ratio = 0.78 [95% CI, 0.35 to 1.76]; P = .56). Of the other 8 reported prespecified secondary end points, including intraoperative complications, postoperative complications, plane of surgery, 30-day mortality, bladder dysfunction, and sexual dysfunction, none showed a statistically significant difference between groups. CONCLUSIONS AND RELEVANCE: Among patients with rectal adenocarcinoma suitable for curative resection, robotic-assisted laparoscopic surgery, as compared with conventional laparoscopic surgery, did not significantly reduce the risk of conversion to open laparotomy. These findings suggest that robotic-assisted laparoscopic surgery, when performed by surgeons with varying experience with robotic surgery, does not confer an advantage in rectal cancer resection. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN80500123.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Jayne D, Pigazzi A, Marshall H, et al. Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. JAMA. 2017. PMID: 29067426. doi:10.1001/jama.2017.7219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。